We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
24.50 | 1.41% | 1,758.00 | 1,757.50 | 1,758.00 | 1,767.00 | 1,736.00 | 1,736.00 | 2,998,928 | 16:06:53 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.68 | 72.36B |
Date | Subject | Author | Discuss |
---|---|---|---|
27/4/2017 10:17 | dazzler, if you can identify better opportunities in the interim, yes agree. | essentialinvestor | |
27/4/2017 10:09 | BUT, the price WILL move up to 2000 and beyond ... eventually ......;0) Go to previousJump to the specified articleSubmit There is a massive opportunity cost to that thinking Michael. | bigdazzler | |
27/4/2017 10:06 | 27th april Kepler reduce tp 1500p 27th april JP Morgan neutral - 27th april HSBC buy tp 1970p 27th april Deutsche hold tp 1700p cut from 1720p reiterations | philanderer | |
27/4/2017 10:05 | Either way, 20 years of dividends at 5% means you own your holding for £0...... ;0) | tradermichael | |
27/4/2017 10:01 | The point being made is that you can pick your price on a long term view. Sure it has been 2000, (but 20 years ago). Of course you can make lots of trades on the day-to-day movements, and accumulate a good profit. Its hard work, and there's always the chance that you'll get stuck till the long term movement recovers your money. In that case, there's always the dividend! BUT, the price WILL move up to 2000 and beyond ... eventually ......;0) | tradermichael | |
27/4/2017 09:55 | Lol price 20 years ago 1950p price now 1550p, what growth. | montyhedge | |
27/4/2017 09:52 | Michael, that's called a long term view! ). | essentialinvestor | |
27/4/2017 09:49 | Price increased from 1000p up to 1700p in last 10 years .....;0) | tradermichael | |
27/4/2017 09:35 | NY, out of interest, why are you so convinced in the Immediate term upside?. There looks to be nice medium term upside to me, however daily share price direction is not something I could call. | essentialinvestor | |
27/4/2017 09:02 | Just taking a IG index long @ 1546p as didn't want to tie up another £5-10k as a stock purchase. | ny boy | |
27/4/2017 08:38 | Great buying opportunity at these prices, imo. Just bought some more and happy to average down on any further drop. | woodhawk | |
27/4/2017 08:31 | The weaker pound/strong dollar generates an income cash boost for GSK (not to be sneezed at) .... ;0) | tradermichael | |
27/4/2017 08:31 | Great buying/topping up opportunity coming up! | ny boy | |
27/4/2017 08:29 | 1400's? I don't think so. The company is moving ahead very strongly: "New product sales of £1.4 billion +72% AER, +52% CER. On track to deliver £6 billion (CER) sales in 2018" .......... ;0) | tradermichael | |
27/4/2017 08:21 | Support is at 1510p but doubt it will go that low, for sure I will buy more just above that level, given the chance. Divi is comforting anyway. | ny boy | |
27/4/2017 08:13 | Stating below the recent low could spell trouble and short term we could be heading to the low 1500's. It could even end up returning into the 1400's. | bigdazzler | |
27/4/2017 08:03 | One day they may do well and increase the dividend. | montyhedge | |
27/4/2017 00:14 | 'Blockbuster drugs will lead sales bonanza at £81bn GlaxoSmithKline, as first female boss lays bare her vision for the FTSE giant' Read more: | philanderer | |
26/4/2017 23:30 | NY, I'm guessing you are holding a few by now!. Michael mentioned how many GSK he holds recently, think it was over 30,000 shares, nerves of steel, or rich, may be both ). | essentialinvestor | |
26/4/2017 23:07 | Now when we compare the intrinsic value of £17.57 to the current share price of £15.99 we see GlaxoSmithKline (LSE:GSK) is a touch undervalued at a 9% discount to what it is available for right now. | ny boy | |
26/4/2017 20:58 | 'GlaxoSmithKline: Good News, 2016's Positive Momentum Continues' | philanderer | |
26/4/2017 19:54 | This is the CEO on today's Q&A (transcript from Seeking Alpha). .."just to reiterate, beyond any kind of update on restructuring programs, it's something that Simon and I are discussing a lot and with the leadership team, a much more disciplined focus on general running costs and cash consciousness across the whole company...' So scope for some margin improvement imv, notice Emma's phrase ... a much more disciplined focus. | essentialinvestor | |
26/4/2017 19:38 | Added more at 1572, a bit too early! Will add more as an when funds available under 16 quid. | spoole5 | |
26/4/2017 18:55 | Will add more tomorrow if the market lets me, great solid blue chip company | ny boy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions